Clinical Trial Update: Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of secukinumab in patients with psoriatic arthritis and axial spondyloarthritis including active enthesitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis
• Enthesitis
• Psoriatic Arthritis

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Psoriatic Arthritis, Axial Spondyloarthritis | Phase 3 | Status: COMPLETED | Results posted: 2021-01-27